We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
HSKA

Price
-
Stock movement up
+- (%)
Company name
Heska Corporation
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Medical Devices
Markedsværdi
1.31B
Ent værdi
1.34B
Pris/omsætning
6.32
Pris/bog
992.83
Udbytte afkast
0.33%
Udbyttevækst
-
Vekst år
-
FCF-udbetaling
-
Efterfølgende P/E
-
Fremtidig P/E
799.93
PEG
-
EPS-vekst
-
1 års afkast
31.18%
3 års afkast
13.53%
5 års afkast
2.42%
10 års afkast
32.94%
Senest opdateret: 2024-12-17

UDBYTTE

HSKA betaler ikke udbytte

VÆRDIANSÆTTELSE

Værdiansættelsesforhold

Loading...
Værdiansættelsesforhold-data
Efterfølgende P/E-
Pris til OCF-
Pris til FCF-
Pris til EBITDA1084.96
EV i forhold til EBITDA1111.03

Værdiansættelse (salg/bogført værdi)

Loading...
Værdiansættelse (salg/bogført værdi)-data
Pris til omsætning6.32
Pris til egenkapital992.83
EV i forhold til salg6.47

ØKONOMI

Pr. aktie

Loading...
Data pr. aktie
Aktuelt antal aktier10.91M
EPS (TTM)-3.04
FCF pr. aktie (TTM)-3.57

Resultatopgørelse

Loading...
Resultatopgørelse-data
Omsætning (TTM)207.37M
Bruttofortjeneste (TTM)88.01M
Driftsindkomst (TTM)-12.68M
Nettoindkomst (TTM)-15.01M
EPS (TTM)-3.04
EPS (1 år frem)0.15

Marginer

Loading...
Marginer-data
Bruttomargin (TTM)42.44%
Driftsmargin (TTM)-6.12%
Fortjenstmargin (TTM)-7.24%

Balance

Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Balancedata
Kontanter4.69M
Nettotilgodehavender9.85M
Omsætningsaktiver i alt26.98M
Goodwill0.00
Immaterielle aktiver2.16M
Ejendomme, anlæg og udstyr0.00
Sum aktiver37.47M
Kreditor7.38M
Kortfristet/nuværende langsigtet gæld12.26M
Summen af kortfristede forpligtelser25.15M
Sum gæld36.15M
Aktionærernes egenkapital1.32M
Materielle nettoaktiver0.00

Likviditet

Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Kontantstrøm-data
Likviditet fra driften (TTM)-14.04M
Investeringsudgifter (TTM)3.57M
Fri pengestrøm (TTM)-17.61M
Udbetalt udbytte (TTM)0.00

Finansiel indkomst

Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Data om finansiel indkomst
Egenkapitalafkast-1138.13%
Afkast af aktiver-40.06%
Afkast af investeret kapital-110.73%
Kontant afkast af investeret kapital-129.88%

INFORMATION OM AKTIER

Nedsidepotensial

Loading...
Nedsidepotensial-data
HSKAS&P500
Nuværende prisfald fra top notering-56.24%-8.59%
Højeste prisfald-98.97%-56.47%
Højeste efterår dato9 Mar 20099 Mar 2009
Gennemsnitlig fald fra toppen-75.28%-11.07%
Gennemsnitlig tid til nyt højdepunkt148 days12 days
Maks. tid til nyt højdepunkt5716 days1805 days
OPLYSNINGER OM VIRKSOMHEDEN
HSKA (Heska Corporation) company logo
Markedsværdi
1.31B
Markedsværdi kategori
Small-cap
Beskrivelse
Heska Corporation manufactures and sells diagnostic and specialty products and solutions for veterinary practitioners in the United States, Canada, Mexico, Germany, Italy, Spain, France, Switzerland, Australia, and Malaysia. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and electrolyte analysis; Element RC, Element RCX, and Element RC3X chemistry systems for blood chemistry and electrolyte analysis; Element HT5 and scil Vet abc Plus veterinary hematology analyzers to measure blood cell, platelet count, and hemoglobin levels; Element POC blood gas and electrolyte analyzers; Element i immunodiagnostic analyzers; and Element COAG and Element AIM veterinary analyzers. It also provides HeskaView Telecytology that provides in-clinic automated microscopic slide scanning and computing equipment; IV infusion pumps; digital radiography hardware and mobile digital radiography products; ultrasound systems; Cloudbank, a Web-based image storage solution; point-of-care products to detect antigens and antibodies associated with infectious and parasitic diseases of animals; Tri-Heart Plus chewable tablets for the treatment of canine heartworm infection, and ascarid and hookworm infections; and allergy products and services, including ALLERCEPT definitive allergen panels and therapy shots or drops. In addition, the company provides a line of bovine vaccines; biological and pharmaceutical products to other animal health companies; turnkey services comprising research, licensing, production, labeling, and packaging; and validation support and distribution services. It sells its products to veterinarians through a telephone sales force and third-party distributors; and trade shows, print advertising, and other distribution relationships. The company was formerly known as Paravax, Inc. and changed its name to Heska Corporation in 1995. The company was incorporated in 1988 and is based in Loveland, Colorado.
Personale
808
Investor relationer
-
SEC-indsendelser
Adm. direktør
Kevin S. Wilson
Land
USA
By
Loveland
Aktietype
Common stock
CCC-status
-
Utbyttefrekvens
Kvartalsvis
ARRANGEMENTER OG PRÆSENTATIONER
ArrangementerPræsentationer
Loading...
FORSTÅ FORRETNINGEN
Loading...
NYHEDER OM VIRKSOMHEDEN
Seeking AlphaPressemeddelelser
Ingen varer fundet
iO Charts is a Seeking Alpha partner